Glucagon-like peptide-1 (GLP-1) agonists in the treatment of obesity
Background: Obesity is an increasing problem in the modern world due to increased morbidity and due to its clinical consequences. It is a chronic disease that causes the development of numerous complications, such as cardiovascular diseases, type 2 diabetes or cancer. The problem of the excessive bo...
Saved in:
Main Authors: | Magdalena Mazurek (Author), Edyta Białowąs (Author), Ewelina Dybała (Author), Iwona Cuber (Author), Artur Aghadi (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023) -
Irritable bowel syndrome - a literature review
by: Iwona Cuber, et al.
Published: (2023) -
Pain therapy in the pediatric population
by: Edyta Białowąs, et al.
Published: (2023) -
Erythropoietin as banned substance in professional sports: effects on maximal aerobic capacity, endurance and detection methods - a review
by: Artur Aghadi, et al.
Published: (2023) -
Central Serous Chorioretinopathy or a stressful lifestyle predisposes to the disease? - review of the current literature
by: Ewelina Dybała, et al.
Published: (2023)